Kemnay Advisory Services’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
TP
Kemnay Advisory Services's MRNA Position: Q2 2026 in Review
Kemnay Advisory Services increased its Moderna (MRNA) stake by 4.8% in Q2 2026, buying an estimated $362 and bringing the position to 154 shares worth $10.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1028.
Kemnay Advisory Services first reported a position in MRNA in Q3 2021 and has held it in 3 quarters since. The position peaked at $414K in Q3 2021. 782 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.
- Kemnay Advisory Services held 154 shares of Moderna worth $10.8K as of Q2 2026.
- Kemnay Advisory Services bought 7 Moderna shares in Q2 2026, an estimated $362.
- Moderna made up ﹤0.01% of Kemnay Advisory Services's portfolio in Q2 2026, its #1028 holding.
- Kemnay Advisory Services first reported a position in Moderna in Q3 2021 and has held it in 3 quarters since.
- Kemnay Advisory Services's Moderna position peaked at $414K in Q3 2021.
- 782 funds tracked by Wall St. Rank held Moderna as of Q2 2026.
Based on Kemnay Advisory Services's 13F filing for Q2 2026, filed 14 Aug 2026.